Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 3/20 | 0.50 |
| ▸ | CHRNA4 | P43681 | 3/20 | 0.50 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | CHRM5 | P08912 | 3/20 | 0.43 |
| ▸ | CHRM3 | P20309 | 3/20 | 0.43 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.43 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.43 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.43 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.42 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.41 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20707 | 1.00 | CHRNB2 (0.50) | CHRNB2CHRNA4CHRNA7MEN1CYP2D6 | |
| SCHEMBL3925606 | 1.00 | CHRNB2 (0.50) | CHRNB2CHRNA4CHRNA7MEN1CYP2D6 | |
| SCHEMBL30824585 | 1.00 | CHRNB2 (0.50) | CHRNB2CHRNA4CHRNA7MEN1CYP2D6 | |
| SCHEMBL3926825 | 1.00 | CHRNB2 (0.50) | CHRNB2CHRNA4CHRNA7MEN1CYP2D6 | |
| Hydrochloric Acid SCHEMBL28366949 | 0.98 | CHRNB2 (0.49) | CHRNB2CHRNA4CHRNA7MEN1CYP2D6 | |
| Hydrochloric Acid SCHEMBL2039471 | 0.98 | CHRNB2 (0.49) | CHRNB2CHRNA4CHRNA7MEN1CYP2D6 | |
| Hydrochloric Acid SCHEMBL31095337 | 0.98 | CHRNB2 (0.49) | CHRNB2CHRNA4CHRNA7MEN1CYP2D6 | |
| Hydrochloric Acid SCHEMBL28366948 | 0.98 | CHRNB2 (0.49) | CHRNB2CHRNA4CHRNA7MEN1CYP2D6 | |
| SCHEMBL3536308 | 0.95 | CHRNB2 (0.51) | CHRNB2CHRNA4CHRNA7MEN1CYP2D6 | |
| SCHEMBL3163175 | 0.95 | CHRNB2 (0.51) | CHRNB2CHRNA4CHRNA7MEN1CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118356774-B | Low-energy-consumption high-selectivity composite desulfurization solvent and preparation method thereof | 江苏创新石化有限公司 | 2025-02-14 | — | — | CN | claimed |
| CN-118356774-A | Low-energy-consumption high-selectivity composite desulfurization solvent and preparation method thereof | 江苏创新石化有限公司 | 2024-07-19 | — | — | CN | claimed |
| CN-118356774-B | Low-energy-consumption high-selectivity composite desulfurization solvent and preparation method thereof | 江苏创新石化有限公司 | 2025-02-14 | — | — | CN | disclosed |
| CN-118356774-B | Low-energy-consumption high-selectivity composite desulfurization solvent and preparation method thereof | 江苏创新石化有限公司 | 2025-02-14 | — | — | CN | disclosed |
| CN-115894447-B | METTL3 inhibitors and uses thereof | 成都先导药物开发股份有限公司 | 2024-10-01 | — | — | CN | disclosed |
| CN-118356774-A | Low-energy-consumption high-selectivity composite desulfurization solvent and preparation method thereof | 江苏创新石化有限公司 | 2024-07-19 | — | — | CN | disclosed |
| US-20230133132-A1 | NAMPT MODULATORS | CYTOKINETICS, INC. | 2023-05-04 | — | — | US | disclosed |
| CN-115894447-A | METTL3 inhibitors and uses thereof | 成都先导药物开发股份有限公司 | 2023-04-04 | — | — | CN | disclosed |
| CN-110627812-B | Heterocyclic compounds as TRK inhibitors | 北京诺诚健华医药科技有限公司 | 2022-10-11 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230133132-A1 | NAMPT MODULATORS | NAMPT, MC4R, SIRT1 | CHRNB2 2815/4885CHRNA4 2484/4885CHRNA7 2536/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.